Level Biotechnology Inc. (TPEX:3118)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.75
+0.10 (0.32%)
Aug 4, 2026, 1:30 PM CST

Level Biotechnology Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
718.58736.59731.35660.61593.01677.28
Revenue Growth
-1.56%0.72%10.71%11.40%-12.44%0.71%
Gross Profit
262.07257.7237.13219.55202.59232.5
Operating Income
89.3583.5575.3267.5564.978.96
Net Income
77.1579.764.8162.9158.4768.18
Earnings Per Share
2.362.441.991.931.792.09
EPS Growth
17.43%22.61%3.11%7.82%-14.35%17.42%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Reagent Consumable Materials Trading
371.37370.01378.15384.6358.61410.72
Entrusted Biotechnology Service Sales
133.77126.86136.76112.1699.63110.27
Instrument and Equipment Trading
213.43239.73216.44163.86134.77156.28
Total
718.58736.59731.35660.61593.01677.28

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
223.26210.34252.78467.41463.5472.96
Total Debt
7.897.9812.6813.4112.5713.18
Net Cash (Debt)
215.37202.36240.1453.99450.92459.78
Net Cash Growth
-12.37%-15.72%-47.11%0.68%-1.93%26.15%
Net Cash Per Share
6.596.197.3513.9013.8014.08

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
63.959.6164.170.2165.07155.95
Capital Expenditures
-30.4-32.67-223.68-7.67-6.74-9.16
Free Cash Flow
33.526.94-159.5862.5458.33146.8
Free Cash Flow Growth
---7.22%-60.26%81.93%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
36.47%34.98%32.42%33.23%34.16%34.33%
Operating Margin
12.43%11.34%10.30%10.23%10.95%11.66%
Pretax Margin
13.36%13.25%11.09%11.91%12.34%12.53%
Profit Margin
10.74%10.82%8.86%9.52%9.86%10.07%
FCF Margin
4.66%3.66%-21.82%9.47%9.84%21.67%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
2.2002.2001.8001.7001.7001.900
Dividend Per Share Growth
22.22%22.22%5.88%0%-10.53%18.75%
Dividend Yield
6.95%7.13%6.35%6.62%7.70%8.48%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
13.4113.4416.0215.7115.3514.26
P/FCF Ratio
30.6639.75-15.8015.386.62
PS Ratio
1.431.451.421.501.511.44